Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502987227

Cayman Chemical Ridaifen-B, Purity: ≥98%, CAS: 886465-70-9, 5 mg
SDP

Catalog No. 502987227
Encompass_Preferred

An antagonist of ERα (IC50 = 52.4 nM), an inverse agonist of CB2 (Ki = 43.7 nM), and a derivative of tamoxifen; selective for CB2 over CB1 receptors (Ki = 732 nM); designed to be cytotoxic to cancer cells independent of ER binding; it inhibits growth of ER-positive and ER-negative cells in a panel of 39 cancer cell lines (GI50s = 0.20-2.14 µM); induces apoptosis and autophagy in ER-negative Jurkat cells at 0.4 µM; decreases NO production and protein levels of IL-1α and IL-6 in LPS-stimulated RAW 264.7 cells at 1 µM

Catalog No. 50-298-7227 Supplier Cayman Chemical Supplier No. 219665 MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

An antagonist of ERα (IC50 = 52.4 nM), an inverse agonist of CB2 (Ki = 43.7 nM), and a derivative of tamoxifen; selective for CB2 over CB1 receptors (Ki = 732 nM); designed to be cytotoxic to cancer cells independent of ER binding; it inhibits growth of ER-positive and ER-negative cells in a panel of 39 cancer cell lines (GI50s = 0.20-2.14 µM); induces apoptosis and autophagy in ER-negative Jurkat cells at 0.4 µM; decreases NO production and protein levels of IL-1α and IL-6 in LPS-stimulated RAW 264.7 cells at 1 µM

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.